Financial Architects (New Jersey)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-774
| Closed | -$38K | – | 275 |
|
|
2020
Q2 | $38K | Buy |
+774
| New | +$38K | 0.01% | 460 |
|
|
2019
Q2 | – | Sell |
-670
| Closed | -$18K | – | 1065 |
|
|
2019
Q1 | $18K | Sell |
670
-200
| -23% | -$5.37K | ﹤0.01% | 808 |
|
|
2018
Q4 | $14K | Buy |
870
+200
| +30% | +$3.22K | ﹤0.01% | 802 |
|
|
2018
Q3 | $14K | Sell |
670
-450
| -40% | -$9.4K | ﹤0.01% | 871 |
|
|
2018
Q2 | $17K | Buy |
1,120
+200
| +22% | +$3.04K | ﹤0.01% | 844 |
|
|
2018
Q1 | $21K | Buy |
920
+350
| +61% | +$7.99K | ﹤0.01% | 762 |
|
|
2017
Q4 | $17K | Buy |
570
+450
| +375% | +$13.4K | ﹤0.01% | 881 |
|
|
2017
Q3 | $5K | Sell |
120
-1,100
| -90% | -$45.8K | ﹤0.01% | 1164 |
|
|
2017
Q2 | $34K | Buy |
1,220
+800
| +190% | +$22.3K | 0.01% | 706 |
|
|
2017
Q1 | $14K | Sell |
420
-630
| -60% | -$21K | ﹤0.01% | 940 |
|
|
2016
Q4 | $30K | Sell |
1,050
-350
| -25% | -$10K | 0.01% | 706 |
|
|
2016
Q3 | $45K | Buy |
1,400
+800
| +133% | +$25.7K | 0.01% | 591 |
|
|
2016
Q2 | $19K | Buy |
+600
| New | +$19K | 0.01% | 785 |
|